Illumina: Corrective RallyILMN recently extended its advance but has begun to show mild signs of weakness again. Imminent additional upside momentum should still emerge, allowing the stock to push above the $156.66 resistance and establish the final high of the current corrective rally. After that, stronger selling pressure
Key facts today
Illumina (ILMN) will release Q1 2026 results on Thursday, April 30, 2026. No guidance, preliminary figures, release time or conference call/webcast were provided.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
5.48 USD
850.00 M USD
4.34 B USD
148.60 M
About Illumina, Inc.
Sector
Industry
CEO
Jacob Thaysen
Website
Headquarters
San Diego
Founded
1998
IPO date
Jul 28, 2000
Identifiers
3
ISIN US4523271090
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Related stocks
Illumina (ILMN) Shows Renewed Demand After High-Volume PullbackIllumina, Inc. (ILMN) is attracting demand following a decisive pullback that occurred on strong trading volume, with approximately 2.3 million shares exchanged versus a daily average of 1.8 million. From a technical perspective, the stock remains in a constructive uptrend, characterized by higher h
Genetic SequencingA Company Dominating Genetic Sequencing
This company stands out in genetic sequencing and could gain enormous benefits from applying AI to analyze the billions of data points it holds.
The price broke out this week and is now heading toward $156.60 to confirm the bullish move by closing a candle a
$ILMNIllumina, a global leader at the forefront of genomic science, continues its mission to improve human health by unlocking the transformative power of the genome. Through a sustained commitment to technological innovation, the company has solidified its position as an industry pioneer in both DNA seq
Outbreak with HesitationAlready on May 12th we had left the trading range since 23rd April but then the price has fluctuated around the outbreak level.
After the last backtest of the upper band of the edge it seems that we can go ahead now.
As we could not fall back into the range we seem to get momentum now. A new high wo
ILMN - Bullish trade This is a 4 hour chart and the arrow is pointing at the 200MA on that 4 hour chart. This is a great breakout that should hit that 200MA in the coming days. You can either buy the shares or for small ccounts you can either sell puts 7 days out just below your entry and collect premium or buy a call a
$NASDAQ:ILMN - analysis of annual cot levelsNASDAQ:ILMN
Please remember that this idea does not constitute investment advice.
After a personal analysis of the institutional value of the COT, buy and sell program levels are outlined. Since the asset is at its minimum, the idea is to wait for the price to head inside the buy program, wait fo
ILMN Illumina Options Ahead of Earnings Analyzing the options chain and the chart patterns of ILMN Illumina prior to the earnings report this week,
I would consider purchasing the 140usd strike price in the money Calls with
an expiration date of 2024-12-20,
for a premium of approximately $16.65.
If these options prove to be profitable pri
ILMN Long PositionHi traders,
Taking a closer look at Illumina, Inc. (ILMN), we can observe the formation of a falling wedge pattern over the past few weeks, indicating a potential bullish reversal.
Illumina, a leading developer of life science tools and integrated systems for large-scale analysis of genetic variati
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of ILMN is 123.67 USD — it has decreased by −3.11% in the past 24 hours. Watch Illumina, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Illumina, Inc. stocks are traded under the ticker ILMN.
ILMN stock has fallen by −0.34% compared to the previous week, the month change is a −0.24% fall, over the last year Illumina, Inc. has showed a 77.37% increase.
We've gathered analysts' opinions on Illumina, Inc. future price: according to them, ILMN price has a max estimate of 170.00 USD and a min estimate of 80.00 USD. Watch ILMN chart and read a more detailed Illumina, Inc. stock forecast: see what analysts think of Illumina, Inc. and suggest that you do with its stocks.
ILMN reached its all-time high on Feb 12, 2021 with the price of 540.12 USD, and its all-time low was 0.83 USD and was reached on Mar 13, 2003. View more price dynamics on ILMN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ILMN stock is 4.32% volatile and has beta coefficient of 1.60. Track Illumina, Inc. stock price on the chart and check out the list of the most volatile stocks — is Illumina, Inc. there?
Today Illumina, Inc. has the market capitalization of 18.91 B, it has increased by 3.63% over the last week.
Yes, you can track Illumina, Inc. financials in yearly and quarterly reports right on TradingView.
Illumina, Inc. is going to release the next earnings report on Apr 28, 2026. Keep track of upcoming events with our Earnings Calendar.
ILMN earnings for the last quarter are 1.35 USD per share, whereas the estimation was 1.24 USD resulting in a 8.70% surprise. The estimated earnings for the next quarter are 1.06 USD per share. See more details about Illumina, Inc. earnings.
Illumina, Inc. revenue for the last quarter amounts to 1.16 B USD, despite the estimated figure of 1.12 B USD. In the next quarter, revenue is expected to reach 1.07 B USD.
ILMN net income for the last quarter is 334.00 M USD, while the quarter before that showed 150.00 M USD of net income which accounts for 0.00% change. Track more Illumina, Inc. financial stats to get the full picture.
No, ILMN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 10, 2026, the company has 8.6 K employees. See our rating of the largest employees — is Illumina, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Illumina, Inc. EBITDA is 1.17 B USD, and current EBITDA margin is 26.14%. See more stats in Illumina, Inc. financial statements.
Like other stocks, ILMN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Illumina, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Illumina, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Illumina, Inc. stock shows the sell signal. See more of Illumina, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.









